XML 101 R80.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Segment and Geographic Information Segment and Geographic Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2015 | Sep. 30, 2015 | Jun. 30, 2015 | Mar. 31, 2015 | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Asset impairments |  |  |  |  |  |  |  |  | $ 253,560 |  | $ 0 |  | $ 0
Asset Impairments Charges and Other PP&E Impairment |  |  |  |  |  |  |  |  | 255,116 |  | 0 |  | 0
Sales to external customers |  |  |  |  |  |  |  |  | 1,040,160 |  | 1,192,952 |  | 1,177,438
Depreciation and amortization expense |  |  |  |  |  |  |  |  | 45,448 |  | 43,176 |  | 40,389
Operating income (loss) | $ (238,918) | $ 15,609 | $ 25,129 | $ 14,957 | $ 41,612 | $ 40,355 | $ 34,044 | $ 22,146 | (183,223) | [1],[2] | 138,157 | [3],[4] | 135,997
Total assets (2) | 1,201,976 |  |  |  | 1,462,063 |  |  |  | 1,201,976 |  | 1,462,063 |  | 1,461,630
Capital expenditures |  |  |  |  |  |  |  |  | 47,039 |  | 62,135 |  | 72,585
Escrow Settlement |  |  |  |  |  |  |  |  | 5,003 |  |  |  |
Segments, Geographical Areas [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment, net | 266,277 |  |  |  | 257,645 |  |  |  | 266,277 |  | 257,645 |  | 224,205
United States [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 513,691 |  | 560,846 |  | 479,067
Segments, Geographical Areas [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment, net | 153,987 |  |  |  | 163,425 |  |  |  | 153,987 |  | 163,425 |  | 146,610
CZECH REPUBLIC |  |  |  |  |  |  |  |  |  |  |  |  |
Segments, Geographical Areas [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment, net | 19,742 |  |  |  | 22,511 |  |  |  | 19,742 |  | 22,511 |  | 23,623
China [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 109,978 |  | 188,047 |  | 231,143
Segments, Geographical Areas [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment, net | 79,691 |  |  |  | 57,580 |  |  |  | 79,691 |  | 57,580 |  | 38,569
Germany [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segments, Geographical Areas [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment, net | 12,246 |  |  |  | 13,495 |  |  |  | 12,246 |  | 13,495 |  | 14,618
Other Non-U.S. Countries [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 416,491 |  | 444,059 |  | 467,228
Segments, Geographical Areas [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment, net | 611 |  |  |  | 634 |  |  |  | 611 |  | 634 |  | 785
Non-U.S. Countries [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 526,469 |  | 632,106 |  | 698,371
Segments, Geographical Areas [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment, net | 112,290 |  |  |  | 94,220 |  |  |  | 112,290 |  | 94,220 |  | 77,595
Energy & Chemicals [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Asset Impairments Charges and Other PP&E Impairment |  |  |  |  |  |  |  |  | 68,796 |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 330,968 |  | 388,018 |  | 318,510
Depreciation and amortization expense |  |  |  |  |  |  |  |  | 11,805 |  | 9,649 |  | 8,564
Operating income (loss) |  |  |  |  |  |  |  |  | (8,138) |  | 79,665 |  | 59,671
Total assets (2) | 251,810 |  |  |  | 322,936 |  |  |  | 251,810 |  | 322,936 |  | 277,760
Capital expenditures |  |  |  |  |  |  |  |  | 4,074 |  | 24,834 |  | 34,194
Energy & Chemicals [Member] | Natural gas processing (including petrochemical) applications [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 180,909 |  | 208,706 |  | 175,397
Energy & Chemicals [Member] | Liquefied natural gas applications [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 136,049 |  | 143,870 |  | 114,567
Energy & Chemicals [Member] | Industrial gas applications [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 14,010 |  | 35,442 |  | 28,546
Distribution & Storage [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Asset Impairments Charges and Other PP&E Impairment |  |  |  |  |  |  |  |  | 2,020 |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 487,557 |  | 578,806 |  | 592,616
Depreciation and amortization expense |  |  |  |  |  |  |  |  | 18,289 |  | 16,749 |  | 15,237
Operating income (loss) |  |  |  |  |  |  |  |  | 41,732 |  | 85,213 |  | 93,560
Total assets (2) | 689,112 |  |  |  | 666,451 |  |  |  | 689,112 |  | 666,451 |  | 676,484
Capital expenditures |  |  |  |  |  |  |  |  | 36,835 |  | 29,583 |  | 32,039
Distribution & Storage [Member] | Liquefied natural gas applications [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 115,909 |  | 209,626 |  | 193,032
Distribution & Storage [Member] | Bulk industrial gas applications [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 203,834 |  | 204,214 |  | 241,291
Distribution & Storage [Member] | Packaged gas industrial applications [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 167,814 |  | 164,966 |  | 158,293
BioMedical [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Asset Impairments Charges and Other PP&E Impairment |  |  |  |  |  |  |  |  | 184,300 |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 221,635 |  | 226,128 |  | 266,312
Depreciation and amortization expense |  |  |  |  |  |  |  |  | 12,039 |  | 13,842 |  | 14,618
Operating income (loss) |  |  |  |  |  |  |  |  | (164,284) |  | 25,694 |  | 33,039
Total assets (2) | 224,443 |  |  |  | 396,320 |  |  |  | 224,443 |  | 396,320 |  | 431,763
Capital expenditures |  |  |  |  |  |  |  |  | 3,849 |  | 3,484 |  | 3,370
BioMedical [Member] | Respiratory therapy [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 132,321 |  | 141,273 |  | 175,233
BioMedical [Member] | Life sciences [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 64,641 |  | 65,948 |  | 61,493
BioMedical [Member] | Commercial oxygen generation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 24,673 |  | 18,907 |  | 29,586
Corporate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sales to external customers |  |  |  |  |  |  |  |  | 0 |  | 0 |  | 0
Depreciation and amortization expense |  |  |  |  |  |  |  |  | 3,315 |  | 2,936 |  | 1,970
Operating income (loss) |  |  |  |  |  |  |  |  | (52,533) |  | (52,415) |  | (50,273)
Total assets (2) | $ 36,611 |  |  |  | $ 76,356 |  |  |  | 36,611 |  | 76,356 |  | 75,623
Capital expenditures |  |  |  |  |  |  |  |  | $ 2,281 |  | $ 4,234 |  | $ 2,982
[1] | Includes asset impairment charges of $255,116 for the year ended December 31, 2015, attributed to E&C - $68,796, D&S - $2,020 , and BioMedical - $184,300.
[2] | Includes impairment of goodwill and intangible assets totaling $253,560 as described in Note 3, Asset Impairments, to the consolidated financial statements.
[3] | Includes recovery of $5,003 increasing operating income during the fourth quarter of 2014 from an escrow settlement for breaches of representations and warranties relating to warranty costs (which are in excess of the settlement amount) for certain product lines acquired from AirSep in 2012. We continue to pursue recovery for breaches of representations and warranties related to warranty costs for certain product lines acquired from AirSep in 2012 under our representation and warranty insurance coverage that exists from the acquisition.
[4] | The BioMedical segment’s operating income included recovery of $5,003 increasing operating income for the year ended December 31, 2014 from an escrow settlement for breaches of representations and warranties relating to warranty costs (which are in excess of the settlement amount) for certain product lines acquired from AirSep in 2012.

X
- Definition Asset Impairments Charges and Other PP&E Impairment + References No definition available. + Details
Name: | gtls_AssetImpairmentsChargesandOtherPPEImpairment
Namespace Prefix: | gtls_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Escrow Settlement + References No definition available. + Details
Name: | gtls_EscrowSettlement
Namespace Prefix: | gtls_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=51824106&loc=d3e2420-110228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585 + Details
Name: | us-gaap_AssetImpairmentCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireProductiveAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 + Details
Name: | us-gaap_PropertyPlantAndEquipmentNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentsGeographicalAreasAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_CZ
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_CN
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_DE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=gtls_OtherNonU.S.CountriesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=gtls_NonU.S.CountriesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=gtls_EnergyChemicalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=gtls_NaturalgasprocessingincludingpetrochemicalapplicationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=gtls_LiquefiednaturalgasapplicationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=gtls_IndustrialgasapplicationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=gtls_DistributionStorageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=gtls_BulkindustrialgasapplicationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=gtls_PackagedgasindustrialapplicationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=gtls_BiomedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=gtls_RespiratorytherapyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=gtls_LifesciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=gtls_CommercialoxygengenerationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |